Acute Effect of tDCS in Young Individuals
Launched by FEDERAL UNIVERSITY OF RIO GRANDE DO SUL · Oct 25, 2023
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a technique called transcranial electrical stimulation (tDCS) affects movement, attention, and thinking skills in healthy young people between the ages of 20 and 30. tDCS is a non-invasive method that sends small electrical currents to the brain to see if it can improve motor performance and control over certain bodily functions. The study aims to understand if this stimulation can help enhance various brain functions in everyday activities.
To participate in the trial, you need to be a healthy young adult aged 20-30 years, and both men and women can join. However, certain health conditions may prevent you from participating, such as any history of neurological or psychological diseases, recent injuries that limit movement, or having metal implants in your head. If you decide to join, you’ll be part of research that could help improve our understanding of brain functions and potentially lead to better treatments in the future. The trial is currently not recruiting participants, but it’s an exciting opportunity for those who qualify!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 20-30 years
- • participant of both sex
- Exclusion criteria:
- • history of neurological or psychological diseases;
- • use of any medications that may affect balance control, such as sedative drugs;
- • presence of skeletal muscle injuries such as fracture, ligament injury, muscle tension or low back pain that restricts movement;
- • presence of any sign of involvement of the spinal cord;
- • visual or hearing impairment;
- • musculoskeletal deformities in the lower or upper extremities that may affect the participant's standing posture;
- • skin conditions (e.g., eczema and injuries) on the scalp
- • presence of metal inside the head (outside the mouth) such as splinters, surgical clips or fragments of solder or metal work;
- • implanted devices such as cardiac pacemaker, cochlear implant;
- • score less than 24 points in the Mini Mental State Examination (MMSE)
About Federal University Of Rio Grande Do Sul
The Federal University of Rio Grande do Sul (UFRGS) is a leading academic institution in Brazil, renowned for its commitment to research and innovation in various fields, including health sciences. As a prominent clinical trial sponsor, UFRGS leverages its extensive network of researchers and state-of-the-art facilities to advance medical knowledge and improve patient outcomes. The university is dedicated to conducting rigorous and ethically sound clinical studies, fostering collaborations with healthcare professionals, industry partners, and regulatory bodies to ensure the highest standards of scientific integrity and public health impact.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Porto Alegre, Rs, Brazil
Patients applied
Trial Officials
Taís Malysz
Principal Investigator
Federal University of Health Science of Porto Alegre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported